The groundbreaking success of Viagra, produced by copyright, undeniably revolutionized the approach of erectile dysfunction , and ignited a massive growth in the pharmaceutical sector. However, now, investing in companies reliant on aging blockbuster drugs like Viagra presents a challenging landscape. Copycat competition is aggressive, substantiall